Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
1.74
Dollar change
+0.02
Percentage change
1.16
%
Index- P/E- EPS (ttm)-5.02 Insider Own2.28% Shs Outstand2.62M Perf Week2.35%
Market Cap4.56M Forward P/E- EPS next Y-4.40 Insider Trans0.00% Shs Float2.56M Perf Month-4.40%
Income-12.25M PEG- EPS next Q-1.10 Inst Own1.99% Short Float0.27% Perf Quarter2.35%
Sales0.57M P/S8.00 EPS this Y13.56% Inst Trans- Short Ratio0.40 Perf Half Y-37.18%
Book/sh2.93 P/B0.59 EPS next Y13.73% ROA-78.62% Short Interest0.01M Perf Year-63.38%
Cash/sh3.04 P/C0.57 EPS next 5Y- ROE-98.43% 52W Range1.40 - 7.20 Perf YTD-20.55%
Dividend Est.- P/FCF- EPS past 5Y38.94% ROI-146.95% 52W High-75.83% Beta1.90
Dividend TTM- Quick Ratio3.93 Sales past 5Y55.57% Gross Margin38.37% 52W Low24.29% ATR (14)0.13
Dividend Ex-Date- Current Ratio3.93 EPS Y/Y TTM32.21% Oper. Margin-2199.15% RSI (14)46.34 Volatility8.74% 6.89%
Employees15 Debt/Eq0.13 Sales Y/Y TTM4278.20% Profit Margin-2133.18% Recom3.00 Target Price40.10
Option/ShortNo / Yes LT Debt/Eq0.09 EPS Q/Q-10.91% Payout- Rel Volume0.61 Prev Close1.72
Sales Surprise- EPS Surprise-1.48% Sales Q/Q- EarningsFeb 14 AMC Avg Volume17.21K Price1.74
SMA200.51% SMA50-6.90% SMA200-30.81% Trades Volume10,476 Change1.16%
Feb-21-24 08:01AM
Feb-15-24 10:03AM
Feb-14-24 04:15PM
Feb-07-24 08:00AM
Nov-16-23 09:35AM
04:15PM Loading…
Nov-14-23 04:15PM
Nov-13-23 08:01AM
Nov-06-23 08:01AM
Oct-12-23 10:19AM
Oct-10-23 08:01AM
Oct-04-23 08:01AM
Aug-30-23 08:01AM
Aug-14-23 08:03AM
Aug-10-23 04:15PM
Aug-03-23 08:01AM
08:01AM Loading…
Jul-24-23 08:01AM
Jul-06-23 02:17PM
12:10PM
Jun-30-23 12:42PM
Jun-28-23 04:15PM
Jun-22-23 08:01AM
Jun-21-23 08:01AM
Jun-14-23 08:01AM
Jun-08-23 09:13AM
Jun-01-23 03:51PM
May-22-23 08:01AM
Feb-17-23 06:53AM
Feb-16-23 06:52AM
Feb-15-23 08:41AM
Feb-14-23 04:42PM
04:15PM Loading…
Feb-13-23 04:15PM
Jan-31-23 08:01AM
Jan-30-23 08:01AM
Nov-16-22 11:10AM
Nov-14-22 04:15PM
Nov-02-22 02:43PM
Sep-12-22 08:35AM
Sep-06-22 08:01AM
Aug-17-22 11:42AM
Aug-15-22 08:19AM
Aug-10-22 09:13AM
07:38AM
Aug-09-22 04:30PM
04:15PM
Aug-03-22 12:47PM
Jul-28-22 02:01PM
Jul-11-22 08:01AM
Jun-29-22 11:25AM
Jun-28-22 04:15PM
Jun-21-22 08:01AM
May-24-22 04:21PM
May-21-22 09:20AM
May-17-22 08:01AM
May-09-22 07:10AM
May-02-22 08:01AM
Mar-28-22 08:01AM
Feb-15-22 11:05AM
Feb-14-22 04:15PM
Jan-31-22 08:01AM
Nov-30-21 04:32AM
Nov-12-21 05:00AM
Nov-09-21 04:15PM
Nov-02-21 08:02AM
Oct-12-21 08:01AM
Sep-30-21 08:02AM
Sep-07-21 08:01AM
Aug-12-21 12:50PM
Aug-11-21 12:10PM
Aug-09-21 04:15PM
Jul-29-21 01:32PM
Jul-01-21 10:09AM
Jun-24-21 04:15PM
Jun-21-21 03:27PM
Jun-15-21 09:08PM
Jun-11-21 11:29AM
Jun-10-21 09:10AM
04:32AM
Jun-09-21 02:27PM
10:23AM
06:17AM
Jun-08-21 12:22PM
Jun-03-21 08:01AM
01:25AM
May-25-21 10:10AM
Mar-01-21 08:02AM
Feb-11-21 06:10AM
Feb-10-21 02:30PM
Feb-07-21 01:06AM
Feb-04-21 08:02AM
Jan-29-21 04:32AM
Jan-06-21 08:02AM
Jan-04-21 08:02AM
Dec-16-20 08:02AM
Nov-03-20 08:01AM
Oct-29-20 11:45AM
Oct-28-20 04:15PM
02:30PM
07:41AM
Oct-19-20 08:01AM
Oct-13-20 10:30AM
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.